Maxime Dely: How Plasma Exchange Treats Severe Diseases – “A Simple Act Behind a Complex Therapy”
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared a post on LinkedIn:
“Plasma: the invisible therapy that’s already transforming modern medicine!
Plasma exchanges play a crucial role today in treating many severe conditions. Performed using apheresis, they remove harmful components from the patient’s plasma… a highly technical procedure with often remarkable results.
And for this therapy to exist, one key element is essential: albumin.
A protein available exclusively thanks to plasma donations. Without donors, plasma exchanges simply cannot happen.
A major therapeutic tool
Plasma exchanges are used to treat:
• Autoimmune diseases (myasthenia gravis, Guillain-Barré syndrome…)
• Hematological disorders
• Severe neurological conditions
• Kidney diseases
• Complex immunological disorders
This technique removes autoantibodies, toxins or immune complexes that drive the disease.
Looking ahead: incredible new prospects
Recent studies suggest that plasma exchanges may slow the progression of Alzheimer’s disease, opening the door to new approaches for neurodegenerative conditions.
A promising field that could reshape the future of care for millions of patients.
A simple act behind a complex therapy
Plasma exchanges require large amounts of albumin.
Albumin comes only from plasma donors.
Every donation makes these treatments possible.
A heartfelt thank you to all donors: your generosity saves lives every single day.”
Get the latest from Hemostasis Today.
-
Jul 30, 2026, 18:36Amina Ammar: Evaluating Rivaroxaban Dosing Alignment Across Cockcroft–Gault and eGFR Equations
-
Jul 30, 2026, 18:11Tobias Tritschler: Evaluating Timing, Translation and Preparedness in COVID-19 Anticoagulation Management
-
Jul 30, 2026, 16:05Peter Zdziarski: Today is Chronic Disease Awareness Day
-
Jul 30, 2026, 15:50Ahmad Gharehbaghian: New Blood Transfusion Centers Open in Iran
-
Jul 30, 2026, 15:32Can We Better Protect Hospitalized Patients With Obesity From Venous Thromboembolism? – RPTH Journal
-
Jul 30, 2026, 15:162025 Platelet Transfusion Thresholds: When to Transfuse and When Not to Transfuse – Chokri Ben Lamine
-
Jul 30, 2026, 14:34Flora Peyvandi: Genetics of Early-Onset Coronary Artery Disease in Iranians
-
Jul 30, 2026, 14:22Stéphanie Forté: New Evidence Strengthens the Case for Hydroxyurea in HbSC Disease
-
Jul 30, 2026, 14:09Hilal Ahmad: New Guidelines for Pediatric Ischemic Stroke Management